Navigation Links
Scientists climb Mt. Everest to explain how hearts adapt and recover from low oxygen
Date:1/31/2011

From the highest mountaintop comes a new research report in the FASEB Journal (http://www.fasebj.org) that gets to the bottom of what happens to the hearts of people when exposed to low-levels of oxygen, such as those on Mount Everest or in the intensive care unit of a hospital. In the study, researchers monitored subjects who spent time at the Mount Everest Base Camp and found that the low-level oxygen conditions at the base came caused changes in heart function resembling what is seen in conditions that severely restrict the amount of oxygen to the heart, such as cystic fibrosis, chronic obstructive pulmonary disease, emphysema, pneumonia, and some forms of heart failure. The good news, however, is that in six months, heart function for these mountain climbers returned to normal. This suggests that the same could be true for people in the ICU if the underlying cause can be corrected.

"Understanding how the heart is able to cope with low oxygen will allow better treatment for a range of heart conditions, including types of heart failure and heart attacks," said Cameron Holloway, MBBS, MRCP, FRACP, D.Phil., a scientist involved in the research from the Department of Physiology, Anatomy and Genetics at the University of Oxford in the United Kingdom. "We also hope to use this information to show how the heart is able to cope with other diseases associated with low oxygen levels. These experiments not only allow us to see the effects on healthy hearts, but also contribute to our understanding of how the body copes with diseases."

Scientists studied 14 physicians and scientists as they trekked to the Mount Everest Base Camp. Before and after the trek, heart scans (using a combination of echocardiography, cardiac magnetic resonance, and a specialized scan that assesses chemicals in the heart) were administered to each subject. After the trek, none of these healthy subjects showed any symptoms of heart problems, but the heart scans revealed fuel levels and changes in heart function consistent with what is seen in heart failure patients. All study protocols were repeated within 48 hours post-trek and again six months later. All of the changes returned to baseline values six months after the climb, suggesting that cardiac changes due to hypoxia are extensive but reversible. This also suggests that heart problems experienced by seriously ill patients may be reversible once oxygen levels in the bloodstream are returned to normal.

"Changes in human physiology under extreme conditions that return to normal after re-adjustment have been seen in other environments. For instance, in U.S. Space Shuttle astronauts VO2 peak and peak power input changes after exposure to microgravity return to normal within weeks after reconditioning in normal gravity," said Millie Hughes-Fulford, Ph.D., NASA Science Astronaut; Professor, Department of Biochemistry and Biophysics, UCSF; Director, Laboratory of Cell Growth, VAMC/UCSF; and editorial board member of the FASEB Journal. "The finding of changes in cardiac function after a Mt. Everest trek within months, suggests that decreased PCr/ATP in patients caused by sustained hypoxia may reverse once oxygen levels return to normal."


'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. Scripps Research scientists convert skin cells to beating heart cells
2. Scripps Research scientists reveal key mechanism governing nicotine addiction
3. Scientists determine what makes an orangutan an orangutan
4. Scientists link protein to the insulation of the nervous systems wiring
5. Scientists grow human liver tissue to be used for transplantation
6. Scientists reveal complete structure of HIVs outer shell
7. Scientists: Big city life may alter green attitudes
8. Scientists find the master switch for key immune cells in inflammatory diseases
9. MU scientists find new farming method to reduce greenhouse gases, increase farm yields
10. 7 CAMH scientists win Young Investigator awards focused on breakthrough research
11. Inside a snowstorm: Scientists obtain close-up look at Old Man Winter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... SAN FRANCISCO , June 16, 2016 /PRNewswire/ ... Market size is expected to reach USD ... report by Grand View Research, Inc. Technological proliferation ... and banking applications are expected to drive the ... ) , The development of ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
Breaking Biology Technology: